citalopram has been researched along with Bilateral Headache in 13 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the present study was to evaluate neuroendocrine and behavioural responses to a challenge with the selective serotonin (5-HT) reuptake inhibitor citalopram (Cit) in patients with social anxiety disorder (SAD)." | 9.11 | Citalopram challenge in social anxiety disorder. ( Aluoja, A; Maron, E; Shlik, J; Tru, I; Vasar, V, 2004) |
| "In this randomized trial, patients (diagnosis of DSM-IV-defined major depressive disorder; baseline Hamilton Rating Scale for Depression score of >/= 20) received 1 week of single-blind placebo treatment, followed by 8 weeks of double-blind, fixed-dose treatment with either escitalopram or venlafaxine XR (rapidly titrated to 20 mg/day and 225 mg/day, respectively, in accordance with prescribing information)." | 9.11 | A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder. ( Bielski, RJ; Chang, CC; Ventura, D, 2004) |
| " The aim of the present study was to investigate whether amitriptyline, a combined serotonin and noradrenaline re-uptake inhibitor, modulates the late exteroceptive suppression period (ES2) of temporal muscle activity in chronic tension-type headache." | 9.08 | Amitriptyline, a combined serotonin and noradrenaline re-uptake inhibitor, reduces exteroceptive suppression of temporal muscle activity in patients with chronic tension-type headache. ( Bendtsen, L; Jensen, R; Olesen, J, 1996) |
| "To construct a cost-utility model comparing escitalopram with sertraline in the treatment of major depressive disorders." | 7.74 | Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder. ( Armstrong, EP; Haim Erder, M; Skrepnek, GH, 2007) |
| "The aim of the present study was to evaluate neuroendocrine and behavioural responses to a challenge with the selective serotonin (5-HT) reuptake inhibitor citalopram (Cit) in patients with social anxiety disorder (SAD)." | 5.11 | Citalopram challenge in social anxiety disorder. ( Aluoja, A; Maron, E; Shlik, J; Tru, I; Vasar, V, 2004) |
| "In this randomized trial, patients (diagnosis of DSM-IV-defined major depressive disorder; baseline Hamilton Rating Scale for Depression score of >/= 20) received 1 week of single-blind placebo treatment, followed by 8 weeks of double-blind, fixed-dose treatment with either escitalopram or venlafaxine XR (rapidly titrated to 20 mg/day and 225 mg/day, respectively, in accordance with prescribing information)." | 5.11 | A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder. ( Bielski, RJ; Chang, CC; Ventura, D, 2004) |
| "Fifty-five outpatients with DSM-IV major depressive disorder and a confirmed history of intolerance to fluoxetine (mean final dose = 24." | 5.10 | Citalopram treatment of fluoxetine-intolerant depressed patients. ( Calabrese, JR; Londborg, PD; Shelton, MD; Thase, ME, 2003) |
| " The aim of the present study was to investigate whether amitriptyline, a combined serotonin and noradrenaline re-uptake inhibitor, modulates the late exteroceptive suppression period (ES2) of temporal muscle activity in chronic tension-type headache." | 5.08 | Amitriptyline, a combined serotonin and noradrenaline re-uptake inhibitor, reduces exteroceptive suppression of temporal muscle activity in patients with chronic tension-type headache. ( Bendtsen, L; Jensen, R; Olesen, J, 1996) |
| "To construct a cost-utility model comparing escitalopram with sertraline in the treatment of major depressive disorders." | 3.74 | Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder. ( Armstrong, EP; Haim Erder, M; Skrepnek, GH, 2007) |
| "Efficacy and safety of the following antidepressants: amitryptiline (tricyclic antidepressant), escitalopram (selective inhibitor of serotonin reuptake), milnacipran (selective inhibitor of serotonin and noradrenalin reuptake) and maprotiline (selective inhibitor of noradrenalin reuptake) have been compared during the treatment of 120 patients with chronic daily headache." | 3.74 | [Antidepressants with different action mechanisms in the treatment of chronic daily headache]. ( Amelin, AV; Ignatov, IuD; Miatleva, MI; Skoromets, AA; Tarasova, SV, 2007) |
| "Escitalopram was used as a control for assay sensitivity." | 2.75 | A study of the effects of LY2216684, a selective norepinephrine reuptake inhibitor, in the treatment of major depression. ( Dellva, MA; Dubé, S; Jones, M; Kielbasa, W; Padich, R; Rao, P; Saha, A, 2010) |
| "Citalopram was well tolerated, with only 15% of patients discontinuing for adverse events." | 2.69 | Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression. ( Feighner, JP; Overø, K, 1999) |
| "To assess the risk of headache associated with commonly prescribed antidepressant medications and to examine the impact of medication class, pharmacodynamics and dosage on risk of headache." | 2.58 | Meta-analysis: Second generation antidepressants and headache. ( Bloch, MH; Olten, B; Telang, S; Walton, C, 2018) |
| "Escitalopram (ESC) is a novel selective serotonin reuptake inhibitor that seems to have a favorable side effect profile." | 1.35 | The safety of the electroconvulsive therapy-escitalopram combination. ( Florakis, A; Markatou, M; Masdrakis, VG; Oulis, P; Papadimitriou, GN; Valamoutopoulos, T, 2008) |
| " The age-related differences in the side effect profile may be attributable to altered sensitivity of the serotonergic system." | 1.32 | Age-related differences in the side effect profile of citalopram. ( Barak, Y; Levy, D; Swartz, M; Weizman, R, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Telang, S | 1 |
| Walton, C | 1 |
| Olten, B | 1 |
| Bloch, MH | 1 |
| Ramos-Zúñiga, R | 1 |
| Pérez-Gómez, HR | 1 |
| Gaytán-Martínez, LA | 1 |
| Vega-Ruiz, B | 1 |
| Soto-Rodríguez, S | 1 |
| Rochín-Mozqueda, A | 1 |
| Masdrakis, VG | 1 |
| Oulis, P | 1 |
| Florakis, A | 1 |
| Valamoutopoulos, T | 1 |
| Markatou, M | 1 |
| Papadimitriou, GN | 1 |
| Dubé, S | 1 |
| Dellva, MA | 1 |
| Jones, M | 1 |
| Kielbasa, W | 1 |
| Padich, R | 1 |
| Saha, A | 1 |
| Rao, P | 1 |
| Aggarwal, A | 1 |
| Kumar, R | 1 |
| Sharma, RC | 1 |
| Sharma, DD | 1 |
| Barak, Y | 1 |
| Swartz, M | 1 |
| Levy, D | 1 |
| Weizman, R | 1 |
| Calabrese, JR | 1 |
| Londborg, PD | 1 |
| Shelton, MD | 1 |
| Thase, ME | 1 |
| Shlik, J | 1 |
| Maron, E | 1 |
| Tru, I | 1 |
| Aluoja, A | 1 |
| Vasar, V | 1 |
| Bielski, RJ | 1 |
| Ventura, D | 1 |
| Chang, CC | 1 |
| Armstrong, EP | 1 |
| Skrepnek, GH | 1 |
| Haim Erder, M | 1 |
| Amelin, AV | 1 |
| Tarasova, SV | 1 |
| Ignatov, IuD | 1 |
| Skoromets, AA | 1 |
| Miatleva, MI | 1 |
| Bendtsen, L | 1 |
| Jensen, R | 1 |
| Olesen, J | 1 |
| Feighner, JP | 1 |
| Overø, K | 1 |
1 review available for citalopram and Bilateral Headache
| Article | Year |
|---|---|
Meta-analysis: Second generation antidepressants and headache.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Citalopram; Depression; Double- | 2018 |
6 trials available for citalopram and Bilateral Headache
| Article | Year |
|---|---|
A study of the effects of LY2216684, a selective norepinephrine reuptake inhibitor, in the treatment of major depression.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents; Citalopram; Constipati | 2010 |
Citalopram treatment of fluoxetine-intolerant depressed patients.
Topics: Adult; Aged; Citalopram; Depressive Disorder; Drug Tolerance; Female; Fluoxetine; Headache; Humans; | 2003 |
Citalopram challenge in social anxiety disorder.
Topics: Adolescent; Adult; Anxiety; Behavior; Citalopram; Cross-Over Studies; Double-Blind Method; Female; H | 2004 |
A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Citalopram; Cyclohexanols; Delayed-Action Preparations; De | 2004 |
Amitriptyline, a combined serotonin and noradrenaline re-uptake inhibitor, reduces exteroceptive suppression of temporal muscle activity in patients with chronic tension-type headache.
Topics: Adult; Amitriptyline; Citalopram; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; | 1996 |
Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
Topics: Administration, Oral; Adult; Ambulatory Care; Citalopram; Depressive Disorder; Drug Administration S | 1999 |
6 other studies available for citalopram and Bilateral Headache
| Article | Year |
|---|---|
[Temporal lobe epilepsy and active neurocysticercosis: two representative case reports].
Topics: Albendazole; Anomia; Anthelmintics; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Citalopram | 2015 |
The safety of the electroconvulsive therapy-escitalopram combination.
Topics: Aged; Bipolar Disorder; Citalopram; Combined Modality Therapy; Depressive Disorder, Major; Electroco | 2008 |
Escitalopram induced galactorrhoea: a case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Female; Galactorrhea; Headache; Humans | 2010 |
Age-related differences in the side effect profile of citalopram.
Topics: Adolescent; Adult; Age Factors; Aged; Bradycardia; Chi-Square Distribution; Citalopram; Confidence I | 2003 |
Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder.
Topics: Adult; Antidepressive Agents; Citalopram; Cost-Benefit Analysis; Decision Support Techniques; Depres | 2007 |
[Antidepressants with different action mechanisms in the treatment of chronic daily headache].
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepress | 2007 |